A team led by Howard Chang has contributed key technology to enable new experimental cancer therapy that uses CRISPR to edit immune cells.
Scientists have used CRISPR-Cas9 gene editing technology to decipher the genes critical to the success of a type of cancer drug, antibody-drug conjugates.
Researchers at Stanford have created an algorithm that predicts how likely CRISPR gene editing will yield off-target mutations.
Stanford scientists and collaborators have harnessed CRISPR to replace the mutated gene underpinning the devastating immune disease, SCID-X1.
Scientists at Stanford have developed a tool that helps them track "off-target" gene edits that come as an accidental result of gene editing.
A team of Stanford researchers has investigated several ways to block CRISPR gene editing and have found one that seems to work best.
Scientists use a tweaked version of CRISPR gene editing to turn skin cells into neurons, and simultaneously identify neuron-specific genes.
A new variation of gene-editing technology CRISPR allows scientists to reorganize DNA in a cell's nucleus in three dimensions, altering cell function.
Scientists have used genome editing to pinpoint genes that reveal information about ALS and may even protect against the degeneration of neurons.
